Actinium Pharmaceuticals, Inc. (ATNM) Analysts See $-0.06 EPS; Methanex (MEOH) Shorts Down By 18.13%

May 15, 2018 - By David Stenberg

Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM) Logo

Methanex Corporation (NASDAQ:MEOH) had a decrease of 18.13% in short interest. MEOH’s SI was 5.05 million shares in May as released by FINRA. Its down 18.13% from 6.16M shares previously. With 937,800 avg volume, 5 days are for Methanex Corporation (NASDAQ:MEOH)’s short sellers to cover MEOH’s short positions. The SI to Methanex Corporation’s float is 6.07%. The stock increased 0.72% or $0.5 during the last trading session, reaching $69.95. About 577,318 shares traded. Methanex Corporation (NASDAQ:MEOH) has risen 32.18% since May 15, 2017 and is uptrending. It has outperformed by 20.63% the S&P500.

Analysts expect Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM) to report $-0.06 EPS on May, 21.They anticipate $0.08 EPS change or 57.14% from last quarter’s $-0.14 EPS. The stock increased 2.86% or $0.01 during the last trading session, reaching $0.378. About 461,362 shares traded. Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM) has declined 75.37% since May 15, 2017 and is downtrending. It has underperformed by 86.92% the S&P500.

Methanex Corporation produces and supplies methanol in North America, the Asia Pacific, Europe, and South America. The company has market cap of $5.73 billion. It also purchases methanol produced by others under methanol offtake contracts and on the spot market. It has a 19.22 P/E ratio.

Among 13 analysts covering Methanex Corporation (NASDAQ:MEOH), 6 have Buy rating, 1 Sell and 6 Hold. Therefore 46% are positive. Methanex Corporation had 77 analyst reports since July 27, 2015 according to SRatingsIntel. Raymond James upgraded Methanex Corporation (NASDAQ:MEOH) on Tuesday, May 17 to “Strong Buy” rating. The rating was maintained by RBC Capital Markets on Friday, December 22 with “Hold”. Cowen & Co maintained it with “Buy” rating and $55.0 target in Friday, October 6 report. The stock has “Sector Perform” rating by RBC Capital Markets on Friday, July 31. The firm has “Hold” rating by TD Securities given on Thursday, March 24. The firm has “Market Perform” rating given on Tuesday, January 3 by Raymond James. The company was maintained on Thursday, June 29 by BMO Capital Markets. The stock of Methanex Corporation (NASDAQ:MEOH) has “Buy” rating given on Monday, February 12 by Cowen & Co. The rating was maintained by RBC Capital Markets with “Hold” on Monday, May 29. RBC Capital Markets maintained Methanex Corporation (NASDAQ:MEOH) on Tuesday, September 26 with “Hold” rating.

Another recent and important Methanex Corporation (NASDAQ:MEOH) news was published by Seekingalpha.com which published an article titled: “Methanex Corporation’s (MEOH) CEO John Floren on Q1 2018 Results – Earnings Call Transcript” on April 28, 2018.

Another recent and important Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM) news was published by Seekingalpha.com which published an article titled: “Actinium Pharmaceuticals: Neglected Assets In Niche Oncology” on May 01, 2018.

Investors sentiment decreased to 1.71 in 2017 Q4. Its down 0.29, from 2 in 2017Q3. It turned negative, as 6 investors sold Actinium Pharmaceuticals, Inc. shares while 1 reduced holdings. 1 funds opened positions while 11 raised stakes. 9.46 million shares or 33.30% less from 14.18 million shares in 2017Q3 were reported. Hartford Management accumulated 18,000 shares or 0.01% of the stock. Blackrock holds 0% in Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM) or 657,324 shares. Barclays Public Limited Company, United Kingdom-based fund reported 15,000 shares. Raymond James Fincl Services Advsr Incorporated reported 25,200 shares. Sns Fincl Group Inc Ltd Llc has 0% invested in Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM). Moreover, Da Davidson has 0% invested in Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM). Virtu Fincl Lc has invested 0% in Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM). Art Advsrs Limited Liability Com holds 0% or 39,405 shares in its portfolio. Northern reported 106,388 shares. California Employees Retirement Systems holds 0% of its portfolio in Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM) for 40,000 shares. 191,249 are held by Geode Management Ltd. Bridgeway Cap Mngmt Inc holds 172,300 shares or 0% of its portfolio. Credit Suisse Ag invested in 0% or 810,200 shares. Armistice Ltd Liability Corp has invested 0.3% of its portfolio in Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM). Dowling And Yahnke holds 22,870 shares or 0% of its portfolio.

Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 David Stenberg

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:








Recent Posts